NEW YORK (Reuters Health) – Patients with moderate-to-severe chronic obstructive pulmonary disease have a greater improvement in dyspnea and health status after 12 weeks of treatment with inhaled…
NEW YORK (Reuters Health) – A review of available evidence indicates that colchicine given after cardiac surgery reduces the risk of developing post-pericardiotomy syndrome, or PPS. “The data…
NEW YORK (Reuters Health) – Results of a Mexican study indicate that 2 months of treatment with the antiinflammatory agent diacerein increases insulin secretion and improves A1C levels…
NEW YORK (Reuters Health) – For patients with acute MI given early unfractionated heparin, a switch to bivalirudin before undergoing primary percutaneous coronary intervention results in improved cardiac…
NEW YORK (Reuters Health) – The use of inhaled anticholinergic drugs to treat chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing urinary retention…
NEW YORK (Reuters Health) – In ischemic stroke patients weighing more than 100 kg, the fixed maximum dose limit for intravenous recombinant tissue plasminogen activator (rTPA — alteplase)…
NEW YORK (Reuters Health) – There’s now one more reason for statin loading before percutaneous coronary intervention. As well as reducing myocardial damage, high-dose atorvastatin given shortly before…
NEW YORK (Reuters Health) – Many patients with acute MI have risk factors for shock, which increase the likelihood of adverse outcomes with early initiation of beta-blocker therapy,…
NEW YORK (Reuters Health) – Ventricular pauses associated with the use of ticagrelor don’t result in clinically significant bradycardia, according to a report in the May 10th Journal…
NEW YORK (Reuters Health) – Older people with chronic obstructive pulmonary disease may live longer if started on an inhaled long-acting beta-agonist than an inhaled long-acting anticholinergic, Canadian…